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ABSTRACT
Background: The de novo biosynthesis of fatty acids (DNL) through fatty acid synthase (FASN) in adipocytes is exquisitely regulated by nutrients,
hormones, fasting, and obesity in mice and humans. However, the functions of DNL in adipocyte biology and in the regulation of systemic glucose
homeostasis are not fully understood.
Methods & results: Here we show adipocyte DNL controls crosstalk to localized sympathetic neurons that mediate expansion of beige/brite
adipocytes within inguinal white adipose tissue (iWAT). Induced deletion of FASN in white and brown adipocytes of mature mice (iAdFASNKO
mice) enhanced glucose tolerance, UCP1 expression, and cAMP signaling in iWAT. Consistent with induction of adipose sympathetic nerve
activity, iAdFASNKO mice displayed markedly increased neuronal tyrosine hydroxylase (TH) and neuropeptide Y (NPY) content in iWAT. In contrast,
brown adipose tissue (BAT) of iAdFASNKO mice showed no increase in TH or NPY, nor did FASN deletion selectively in brown adipocytes (UCP1-
FASNKO mice) cause these effects in iWAT.
Conclusions: These results demonstrate that downregulation of fatty acid synthesis via FASN depletion in white adipocytes of mature mice can
stimulate neuronal signaling to control thermogenic programming in iWAT.
 2017 The Authors. Published by Elsevier GmbH. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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1. INTRODUCTION
Adipose tissue metabolism plays a paramount role in regulating energy
balance and metabolic homeostasis, and its disruption is thus closely
associated with metabolic diseases, such as obesity and diabetes [1e
5]. Several studies have demonstrated major beneﬁcial effects of
implantation of adipocytes or adipose tissues derived from insulin
sensitive mice into obese animals [5e8]. Three predominant pathways
have been suggested whereby adipose tissue exerts such control over
whole body glucose homeostasis. One hypothesis proposes a key role
for sequestering triglyceride (TG) within adipocytes, reducing systemic
“lipotoxicity” by keeping lipids away from disrupting sensitive path-
ways in other tissues such as liver and muscle [3,9]. A second concept
focuses on extensive evidence that adipocytes display endocrine
functions that play a pivotal role in controlling whole body metabolism
[1,2,10,11]. Subsequent to the discoveries of the secreted adipose
proteins leptin [12,13] and adiponectin [14], many other adipocyte-
derived peptides that may modulate multiple organs (e.g., liver,
brain, pancreas, skeletal muscle, and heart) important for the
maintenance of energy balance and prevention of metabolic
dysfunction have been identiﬁed [2,10,15e17]. A third concept of how
adipose tissue might regulate systemic metabolic homeostasis invokes
relatively new ﬁndings that brown adipose tissue (BAT) and “beige/
brite” adipocytes within mouse and human white adipose tissues
(WAT) might be major sites of fatty acid oxidation and energy expen-
diture [4,8,18]. These three concepts are not mutually exclusive, and,
together, these pathways may operate synergistically to optimize ad-
ipose tissue depot inﬂuence on overall metabolic ﬂux in mammals.
Initial work on adipocyte metabolism in obesity revealed that the
biosynthesis of palmitate from acetyl CoA, denoted de novo lipogenesis
(DNL), was markedly reduced in the insulin resistant state [19,20] in
spite of near normal glucose uptake [21]. These data suggested a
possible role of DNL disruption in insulin resistance of adipocytes that
was extended to human adipose tissue [22,23]. These ﬁndings were
initially puzzling, because DNL contributes only a few percent of fatty
acids to the TG that accumulates in the lipid droplets of adipocytes
[24e26]. More recently, however, a number of adipose-derived pu-
tative bioactive lipids that arise from DNL [27,28] have been identiﬁed,
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including palmitoleate [29], the novel fatty acidehydroxyefatty acid
(FAHFAs) lipids [30], and the recently identiﬁed PPARg ligand alkyl
ether-lipid (1-O-octadecenyl-2-palmitoyl-3-glycerophosphocholine)
[31]. Beside biosynthesis of fatty acids, the DNL pathway is a rich
source of metabolites known to regulate cellular processes, ranging
from gene transcription to protein post-translational modiﬁcations
(e.g., protein acetylation and palmitoylation) [32e36]. Nonetheless,
experimental genetic manipulation of this pathway in adipocytes has
produced conﬂicting results in terms of systemic effects [29,31,37,38],
and the role of adipocyte DNL in both adipose function and systemic
metabolic regulation remains unclear.
The aim of the present studies was to clarify the physiological role of
adipocyte DNL by generating mouse models in which adipocyte FASN
could be depleted after the animals reach maturity, thereby eliminating
possible confounding effects of FASN knockout during mouse devel-
opment. To this end, we generated a tamoxifen (TAM)-inducible
adipose-speciﬁc FASN knockout mouse line (iAdFASNKO) in which
FASN deletion and inhibition of DNL in adipocytes is initiated in adult
mice. Analysis of these mice following FASN deletion revealed
improved glucose tolerance and showed strong iWAT browning, with
enhanced UCP1 and thermogenic gene expression, as previously found
in constitutive adipocyte FASN knockout mice [31]. Surprisingly,
however, depletion of FASN in primary white adipocytes in vitro failed
to modulate UCP1 or other genes that are characteristically expressed
at high levels in BAT, indicating that a cell autonomous mechanism is
not involved and that an intact animal is required for the browning
effect. This interpretation proved correct, as a markedly increased
sympathetic innervation of iWAT was observed in response to induced
FASN depletion in adipocytes of mature mice.
2. MATERIALS AND METHODS
2.1. Animal studies
Four-week old male C57BL/6J (WT) and B6.V-Lepob/J (ob/ob) mice
were obtained from Jackson Laboratory. Mice were housed on a 12 h
light/dark schedule and had free access to water and food, except
when indicated. WT mice were fed a high fat diet (HFD) that contained
60% calories from lipids (Research Diets, D12492). Mice with condi-
tional FASNﬂox/ﬂox alleles were generated as described elsewhere [31].
To inactivate FASN in adult mice, homozygous FASNﬂox/ﬂox animals
were crossed to Adiponectin-Cre-ERT2 mice (a generous gift from Dr.
Evan Rosen). At eight-weeks of age, both FASNﬂox/ﬂox and FASNﬂox/ﬂox-
Adiponectin-Cre-ERT2 (iAdFASNKO) were then treated once a day via
intraperitoneal (i.p.) injection with 1e2 mg TAM dissolved in corn oil
for 6 consecutive days. FASNﬂox/ﬂox animals were also crossed with
UCP1-Cre mice (Jackson Laboratory stock number 024670) to
generate the UCP1-FASNKO that speciﬁcally delete FASN in brown
adipocytes. For deletion of FASN in cultured primary adipocytes,
FASNﬂox/ﬂox mice were crossed with the TAM-inducible UBC-Cre-ERT2
mice (B6.Cg-Tg(UBC-cre/ERT2)1Ejb/2J mice, stock number 008085)
from Jackson Laboratories.
All of the studies performed were approved by the Institutional Animal
Care and Use Committee (IACUC) of the University of Massachusetts
Medical School.
2.2. Metabolic studies
Glucose and insulin tolerance tests were performed on WT, iAdFASNKO,
or UCP1-FASNKO mice as indicated. Glucose (1 g/kg) was administrated
by i.p. injection. Blood samples were drawn from the tail vein at the
indicated times, and glycemia was determined using a Breeze 2
glucose meter (Bayer and alpha-trak). For the effect of FASN deﬁciency
on glucose tolerance, mice were ﬁrst fed with chow or HFD for 4 weeks
and then injected with vehicle or TAM to induce FASN deletion. Plasma
insulin levels were measured with Millipore insulin ELISA.
2.3. Lipogenesis assay
To assess lipogenesis in vivo, hyperinsulinemic-euglycemic clamps
were performed following an overnight fast, a 2-h hyperinsulinemic
(insulin at 150 mU kg1 body weight priming followed by
2.5 mU kg1 min1)-euglycemic clamp was conducted in awake
mice using [14C]-U-glucose to assess glucose metabolism in adipose
tissue depots as described previously [39]. Tissues were then harvested,
total neutral lipids extracted, and incorporation of glucose into TG or fatty
acids determined as previously described [40]. For lipogenesis ex vivo,
adipose tissue explants were incubated with labeling media containing
2% FA-free BSA, 1% (v/v) Pen/Strep, 0.5 mM D-Glucose, 0.5 mM So-
dium Acetate, 2 mM sodium pyruvate, 2 mM glutamine, 2 mCi/mL 14C-
U-glucose. Insulin at 1 mM was added to insulin-stimulated conditions.
Adipose tissue explants were incubated at 37 C in a humidiﬁed incu-
bator (5% CO2) for 4.5 h before lipid extraction. Glucose incorporation
into TG or into fatty acids was then determined as previously described
[40]. To determine lipogenesis in cultured primary adipocytes, cells were
incubated with labeling media with or without insulin for 4.5 h and total
neutral lipid extracted as described.
2.4. Westerns blots
For in vivo insulin stimulated Akt phosphorylation, mice were fasted for
4 h, injected with phosphate-buffered saline (PBS) or insulin (1 IU/kg),
and 15 min after the injection, tissues were harvested. For protein
expression analyses, tissues were homogenized in lysis buffer (20 mM
HEPES [pH 7.4], 150 mM NaCl, 2 mM EDTA, 1% Triton X-100, 0.1%
SDS, 10% glycerol, 0.5% sodium deoxycholate) that had been sup-
plemented with Halt protease and phosphatase inhibitors (Thermo
Pierce). Samples from tissue lysates were then resolved by SDS-PAGE,
and immunoblots were performed using standard protocols. Mem-
branes were blotted with the following antibodies: AKT (S473 and
total), ACLY, ACC, GAPDH, pHSL-S660, HSL, NPY, and perilipin (Cell
Signaling Technology); FASN (BD Biosciences); UCP1 (Alpha Di-
agnostics); phospho-perilipin-S522 (Vala Sciences); TH (Abcam and
Millipore), Tubulin (SigmaeAldrich). Best results for western blotting of
TH were obtained with Millipore-MAB318 antibody. For the ex vivo
insulin signaling experiments, adipose tissue explants were incubated
in Dulbecco’s Modiﬁed Eagle Medium (DMEM) media supplemented
with 0.5 mM glucose, 2 mM sodium pyruvate and 2 mM glutamine, in
the absence or presence of 1 mM insulin for 30 min. Adipose tissue
explants were then homogenized and total cell lysate immunoblotted
with total and phospho-Akt.
2.5. Adipocyte isolation
For detection of FASN protein on isolated adipocytes, adipose tissues
from control or iAdFASNKO were minced and digested, and the adi-
pocytes were isolated as described previously [41].
2.6. Histological analysis
For the immunohistochemistry (IHC) and immunoﬂuorescence (IF) of
adipose tissue analyses, tissue samples were ﬁxed in 4% para-
formaldehyde and embedded in parafﬁn. Sectioned slides were then
stained for H&E, UCP1 (Abcam) or for TH (Abcam) and DAPI, at UMASS
Medical School Morphology Core. For immunoﬂuorescence analyzes,
photos from the stained adipose tissue sections were taken with an
Axiovert 35 Zeiss microscopy (Zeiss, Germany) equipped with an
Axiocam CCl camera at indicated magniﬁcation.
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2.7. RNA isolation and RT-qPCR
Total RNA was isolated from cultured primary adipocytes or from
mouse tissues using QIAzol Lysis Reagent Protocol (QIAGEN) following
the manufacturer’s instructions. cDNA was synthesized from 1 mg of
total RNA using iScript cDNA Synthesis Kit (BioRad). Quantitative RT-
PCR was performed using iQ SybrGreen supermix on BioRad
CFX97and analyzed as previously described [42,43]. 36B4, Hprt, and
Gapdh served as controls for normalization. Primer sequences used for
qRTePCR analyses were listed in Supplementary Table 1.
2.8. Deletion of FASN in primary adipocyte cell culture
Primary white fat stromal vascular fraction (SVF) and mature fat cells
from inducible-UBC-Cre-FASNKO mice were fractionated according to
published methods [41]. Primary SVF cells were cultured in DMEM/F12
containing 10% FBS, 100 U ml1 penicillin, and 0.1 mg ml1 strep-
tomycin (maintenance medium) until full conﬂuence. Adipocyte dif-
ferentiation was induced in preadipocyte cultures as previously
described [44,45]. Brieﬂy, conﬂuent cells were treated for 48 h in
maintenance medium containing 0.5 mM isobutylmethylxanthine, 60
mM indomethacin, 1 mM dexamethasone, 825 nM insulin and 1 mM
rosiglitazone. Two days after induction, cells were switched to main-
tenance medium containing 825 nM insulin and 1 mM rosiglitazone.
Then four days after induction, cells were switched to maintenance
medium containing 825 nM insulin for 24 h, followed by maintenance
medium only until harvested. For induction of FASN deletion in mature
adipocytes, cells were treated with ethanol vehicle or with TAM (1 mM)
for 24e48 h and medium replaced after this incubation time. Adipo-
cytes were left for a further 48 h before further treatments or harvest.
To determine 14C-glucose conversion into lipids, control and TAM-
treated cells were starved for 2 h, incubated in labeling media with
or without insulin for 4.5 h followed by lipid extraction. To examine the
effect of FASN inhibition on DNL, control cells were preincubated for
1 h with 100 mM of FASN inhibitor platensimycin [46,47], followed by
incubation with labeling media with or without insulin and lipid ex-
tractions after 4.5 h incubation. To stimulate Ucp1 expression, cells
were incubated with indicated CL316243 concentrations for 4 or 24 h,
followed by total protein or RNA extractions for immunoblots or qPCR
quantiﬁcations.
2.9. Statistical analysis
Data were analyzed in GraphPad Prism 7 (GraphPad Software, Inc.).
The statistical signiﬁcance of the differences in the means of experi-
mental groups was determined by Student’s t-test or one-way or two-
way ANOVA and Fisher LSD posttests, as indicated. The data are
presented as means  SE. P values  0.05 were considered
signiﬁcant.
3. RESULTS
3.1. Early onset obesity downregulates DNL but not Akt activation
in mouse adipose tissue
To determine whether the suppression in adipose tissue DNL arises at
an early stage of obesity and whether it correlates with worsening of
systemic glucose homeostasis, we analyzed expression levels of DNL
genes in adipose tissue from diet- and genetically-induced obese
mouse models. Despite the absence of major differences in weight
gain at 5 weeks compared to WT mice, ob/ob mice were already
markedly glucose intolerant and hyperinsulinemic [40], indicating a
systemic metabolic dysfunction in this mouse model at this very early
age. The mRNA expression of several lipogenic transcription factors
and enzymes including Fasn, Acly, and Elovl6 was also already
markedly suppressed in the subcutaneous, inguinal adipose depot
(iWAT) in these 5 week old ob/ob mice compared to WT mice
(Figure 1A). The expression levels of these lipogenesis-related genes
were even further downregulated at 7 and 11 weeks of age. We
conﬁrmed by protein immunoblotting that the protein products of
lipogenic genes in adipose tissue from ob/ob mice were also
decreased (Figure 1B). The DNL enzymes ATP-citrate lyase (ACLY),
acetyl-CoA-carboxylase (ACC) and fatty acid synthase (FASN) were all
signiﬁcantly decreased in abundance in iWAT from 5 week old ob/ob
mice (Figure 1B and Supplementary Figure 1). By contrast, expression
of these lipogenic enzymes was remarkably upregulated in the livers of
such ob/ob mice.
Using [14C]-glucose as tracer, the in vivo and ex vivo rates of TG and de
novo fatty acid biosynthesis in adipose tissue from ob/ob mice were
also measured (Figure 2). While the insulin-stimulated glucose
incorporation into total TG (fatty acid plus glycerol) was not reduced
and basal TG biosynthesis signiﬁcantly increased in the adipose tissue
of ob/ob mice, glucose conversion to triglyceride fatty acids (TG-fatty
acids) was strongly reduced in the adipose tissue of 7 week old ob/ob
mice (Figure 2A). This was conﬁrmed by measuring the rate of
glucose-derived [14C]-labeled carbon incorporation into TG-fatty acids
in adipose tissue explants (ex vivo) in 7 week old and 11 week old mice
(Figure 2B). Therefore, these results are consistent with the conclusion
that DNL activity is severely attenuated at early stages of genetic
obesity in mice. They also suggest that ob/ob mice utilize most of their
glucose to synthesize glycerol in TG instead of fatty acids in adipose
cells.
Since adipose glucose metabolism and ﬂux through the DNL pathway
are known to be regulated by signaling through the protein kinase AKT,
we asked whether the decreased DNL in ob/ob mice might be medi-
ated by disrupted insulin-induced AKT activation. Surprisingly, insulin-
induced AKT activation was not affected by genetic obesity under
conditions where DNL was markedly attenuated (Figure 2C). Together,
these results indicate that inhibition of adipose tissue DNL in young ob/
ob mice occurs independent of insulin signaling to AKT. Interestingly, a
signiﬁcant enhancement of basal AKT phosphorylation was observed in
livers from ob/ob mice at these same ages (Supplementary Figure 2).
We further examined the relationship between systemic glucose intol-
erance, reduction of DNL-related genes and AKT activation in adipose
tissue from mice fed a high fat diet short-term (1e4 weeks). As shown
in Figure 3AeC, HFD feeding to 8 week old mice very rapidly causes
glucose intolerance and insulin resistance. Strikingly, no signiﬁcant
changes in insulin-stimulated AKT activation were detected in adipose
tissue from 1 week fed HFD mice (Figure 3DeE). In contrast, 1 week of
HFD feeding also caused major reductions (about 90%) of several
lipogenic enzymes (such as ACLY, FASN, and ACC) and inhibited adipose
DNL activity (Figure 3FeH). Altogether, the results depicted in
Figures 1e3 suggest that the reduction of adipose DNL and the
worsening of systemic glucose homeostasis in early onset obesity are
strongly correlated (Figure 3I), while hepatic DNL is increased under
these same conditions. Moreover, while rapid and sustained defects in
adipose DNL and in systemic insulin sensitivity were noted, the ability of
insulin to induce phosphorylation of AKT remained intact in adipose
tissue after 1e4weeks of the HFD, reinforcing the notion that resistance
to the actions of insulin on adipose glucose metabolism can be pro-
moted by pathways downstream of insulin signaling to AKT [48].
3.2. Inducible deletion of adipocyte FASN in mature HFD fed mice
improves glucose tolerance
The strong correlation between adipose DNL inhibition and glucose
intolerance in obese mice suggests potential causative actions of
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adipocyte DNL on systemic insulin sensitivity (Figure 3I). This notion is
supported by a recent study reporting that constitutive adipose deletion
of FASN improves glucose homeostasis in dieteinduced obese mice
[31]. To speciﬁcally test whether adipocyte DNL disruption after the
onset of obesity in mice could affect systemic metabolic homeostasis,
we developed an inducible adipocyte FASN KO mouse line in which
deletion of adipocyte FASN can be initiated after the mice attain
maturity. Thus, FASN ﬂoxed mice (with loxP ﬂanked exons 4e8) [31]
were crossed with a TAM-inducible adiponectin-Cre-ERT2 mouse line
[49] to produce iAdFASNKO mice. TAM was administered via i.p.
injections to both FASNﬂox/ﬂox (control) and iAdFASNKO mice
(Figure 4A), leading to a marked reduction of FASN in white and brown
adipose tissue depots from iAdFASNKO mice, but not in liver, brain, or
lung tissue, nor in any tissues in FASNﬂox/ﬂox mice (Figure 4BeC).
Moreover, isolation of adipocytes from TAM-treated iAdFASNKO mice
followed by detection of FASN protein in cell lysates conﬁrmed FASN
reduction in adipocytes (Figure 4D).
We then investigated whether adipocyte deletion of FASN following
diet-induced obesity could improve glucose tolerance. In these ex-
periments, 8 week old mice were ﬁrst fed HFD for 4 weeks to induce
Figure 1: Early onset obesity suppresses expression of genes encoding enzymes in the DNL pathway in adipose tissue, while enhancing expression of these genes in
liver of ob/ob mice. (A): Heat map representing the expression levels of genes involved in the DNL pathway. qPCR analyses were performed to determine relative gene ex-
pressions in epididymal (eWAT), inguinal subcutaneous (iWAT) fat tissues and livers from WT or littermate ob/ob mice at 5, 7, or 11 weeks of age; N ¼ 4 - 5 mice per group. A
green-red scale depicts normalized expression levels in fold-change compared to WT control mice. (B): Depicted are quantiﬁcations of ACLY, FASN, and ACC protein levels in iWAT
or liver tissues from WT control or ob/ob mice at 5, 7, and 11 weeks of age. A.U., arbitrary units. N ¼ 4e5 mice per group. Data are presented as mean /þ SE and were
compared to appropriate controls by Student’s T-test. *P < 0.05; **P < 0.01; ***P < 0.001. ****P < 0.0001.
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Figure 2: Early onset obesity in ob/ob mice downregulates adipose tissue DNL, but not AKT activation. (A): 7 week-old WT or ob/ob mice were fasted overnight and
subjected to a 2 h hyperinsulinemic-euglycemic clamp with [14C]-glucose to assess glucose conversion into lipids. Adipose tissues were then harvested and lipid extracted to
determine glucose incorporation into TG or fatty acids. (B): Insulin-stimulated [14C]-glucose conversion into TG and into TG-fatty acids were measured ex vivo in iWAT derived from
7 or 11 week old WT or ob/ob mice. (C): Representative protein immunoblot of AKT phosphorylation in iWAT in response to a bolus insulin injection (1 U/kg) as described in
Materials and Methods. Bottom panels depict densitometry analysis of the data from the experiment described for top panel (N ¼ 6 or 7). Graphs show the mean /þ SEM. N ¼ 5
to 7 per group, compared with WT controls, by Student’s t test. *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001.
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Figure 3: Short-term HFD-feeding represses DNL but not AKT activation in adipose tissue. (A): C57BL/6J male mice were fed for 1e4 weeks with chow or HFD and
subjected to an oral GTT ($, P < 0.0001, two-way analysis of variance, n ¼ 5). (B): Depicted is the area under the curve for the GTT. (C): Plasma insulin levels in mice fed a chow
or a HFD. (D): Short-term HFD feeding does not inhibit insulin-stimulated AKT activation in adipose tissue. iWAT explants from chow and HFD fed mice were stimulated with insulin
in vitro for 30 min. Tissue lysates were then immunoblotted for total AKT and phospho-AKT (pAKT). (E): Quantiﬁcation of p-AKT levels by densitometry analysis of data depicted in
D. (F): HFD feeding strongly suppresses DNL genes in eWAT. Depicted is a heat map representing the expression levels of DNL genes in adipose tissues. qPCR analyses were
performed to determine gene expression in eWAT from chow and HFD fed mice. N ¼ 5 mice per group. A black-yellow scale depicts normalized expression levels in fold-change
compared to chow fed controls mice. (G, H): Insulin-stimulated [14C]-glucose conversions into TG (G) and into TG-fatty acids (H) were measured in iWAT explants from chow and
HFD fed mice. (I): Suppression of adipose tissue DNL by HFD feeding correlates with systemic glucose intolerance, while AKT activation is preserved. Depicted are the insulin-
stimulated glucose conversions into fatty acids (H), AKT activation (E) and the area under the curve (values multiplied by 103) for GTT (B) in 1e4 weeks HFD fed mice. Graphs
show the mean /þ SEM. N ¼ 5 per group, compared with chow controls. Statistical signiﬁcance was determined by Student’s t-test or two-way ANOVA. *P < 0.05; **P < 0.01;
***P < 0.001.
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glucose intolerance (Figure 4F,G). Then the mice were treated with
vehicle (controls) or with TAM to induce FASN deletion, and glucose
tolerance tests (GTT) were performed 3 weeks and 11 weeks post-
TAM treatment. As depicted in Figure 4G,H, FASN deletion in obese
mice attenuated their glucose intolerance, and this beneﬁcial effect
persisted even 11 weeks after TAM induction. The metabolic
improvement observed after FASN deletion is not due to changes in
food intake (Supplementary Figure 3) and most likely not due to
changes in body weight, as no differences in weight gain in iAdFAN-
SKO mice were detected 11 weeks after deletion, despite persistent
Figure 4: Inducible deletion of adipocyte FASN in mature obese mice improves glucose tolerance. (A): Diagram representing the experimental design of TAM treatment to
activate Cre-recombinase in adipose cells. 8-week-old mice were i.p. injected with 2 mg of TAM solubilized in sunﬂower oil or with sunﬂower oil only (vehicle control) for 6 days.
Experiments were performed on littermate Cre-ERT2 -negative and Cre-ERT2 -positive mice 21 days after the last treatment of TAM. (B, C): TAM treatment induced deletion of
FASN in adipose tissue from Cre-ERT2-positive mice but not in control mice. Epididymal (eWAT), subcutaneous (iWAT), brown fat (BAT), liver, and brain tissue lysates from Cre-
ERT2-positive (Creþ), Cre-ERT2-negative (Cre-), vehicle, or TAM-treated (TAM) mice were immunoblotted for FASN or tubulin as indicated. (D): Isolated adipocytes from epididymal
fat tissue from vehicle or TAM-treated mice were immunoblotted for FASN or tubulin as indicated. (E): Histologic appearance of iWAT harvested from control or induced adipocyte
FASN KO mice (iAdFASNKO). (F): Deletion of adipocyte FASN during HFD-feeding improves glucose tolerance. Diagram representing the experimental design. (G): Eight week old
mice were HFD-fed for 4 weeks, and body weight gain and glucose tolerance measured before the TAM treatment (baseline measurements). At 3 and 13 weeks post-TAM
treatment, glucose tolerance and body weight were measured again. Reductions in body weight gain (I) and attenuation of glucose intolerance (G) were observed in iAd-
FASNKO mice but not control mice. (H) The area under the curve for GTT is depicted. Statistical signiﬁcance was determined by Student’s t-test or two way ANOVA followed by
Fisher LSD posttest. $, P < 0.0001, &, P < 0.001 two-way analysis of variance, n ¼ 4 to 6 mice per group. *P < 0.05; **P < 0.01.
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improvement in glucose tolerance (Figure 4G,I). Thus, these results
indicate that deletion of FASN in mature adipocytes after induction of
obesity in mice ameliorates glucose intolerance, consistent with
causative actions of adipocyte DNL on systemic metabolic
homeostasis.
3.3. Inducible deletion of FASN in mature adipocytes enhances
browning of iWAT without effect on BAT
Based on previous data indicating that constitutive inhibition of adipose
DNL enhances browning in iWAT [31] and the increased multilocularity
of lipid droplets in iWAT from iAdFASNKO mice revealed by
Figure 5: Inducible deletion of adipocyte FASN in mature mice enhances browning of iWAT. (A): qRT-PCR was performed for Ucp1, Cidea, Pgc1a, and Pdk4 mRNA for
quantiﬁcations in iWAT from indicated controls and iAdFASNKO (Creþ, TAM-treated) mice. N ¼ 5e6 per group. (B): Inducible deletion of adipocyte FASN upregulates UCP1 protein
in iWAT. iWAT lysates from controls and TAM-treated mice were immunoblotted for FASN, UCP1 or GAPDH as indicated. (C): Immunohistochemistry for UCP1 of iWAT from control
or iAdFASNKO mice reveals UCP1 upregulation in the latter. Multilocular adipocytes are also detected in iAdFASNKO mice, but not control mice. Depicted are representative images
of 5e7 mice per group. (DeG): qPCR analysis to quantify mRNA expression levels of Fasn, Ucp1, Cidea and Pdk4 in anterior subcutaneous (asWAT), epididymal (eWAT),
retroperitoneal (rpWAT) and mesenteric (mWAT) adipose tissues from control or iAdFASN KO mice as indicated. N ¼ 8 per group. *P < 0.05; **P < 0.01; ****P < 0.0001.
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hematoxylin and eosin (H&E) staining (Figure 4E), we next examined
whether inducible suppression of adipocyte FASN in mature mice also
enhances thermogenic gene expression in WAT. As depicted in
Figure 5A, TAM-induced FASN deletion in adipocytes induced strong
upregulation of Ucp1 mRNA along with increased expression of other
characteristically expressed beige/brite/brown adipocyte genes,
including cell death-inducing DNA fragmentation factor alpha-like
effector A (Cidea), peroxisome proliferator-activated receptor a coac-
tivator 1 (Pgc1a) and pyruvate dehydrogenase kinase isoform 4 (Pdk4)
in iWAT. Immunoblot analysis conﬁrmed that UCP1 protein level was
also enhanced in iWAT from iAdFASNKO mice upon induction of FASN
deletion by TAM (Figure 5B). Moreover, immunohistochemistry anal-
ysis revealed UCP1-positive multilocular adipocytes present in iWAT
following TAM-induction of adipose-speciﬁc FASN knockout in mature
mice, but not in control mice treated with TAM (Figure 5C).
The question of whether inducible adipose FASN deletion could
enhance browning of other adipose depots was also addressed. As
illustrated in Figure 5D, TAM treatment of iAdFASNKO mice efﬁciently
reduced Fasn mRNA expression in anterior subcutaneous (asWAT),
epididymal (eWAT), retroperitoneal (rpWAT), and mesenteric (mWAT)
adipose tissue depots. Interestingly, while asWAT displayed upregu-
lation of Ucp1, Cidea, and Pdk4 mRNA expression upon FASN deletion,
thermogenic gene expression in the other WAT depots was either only
slightly enhanced (e.g., Ucp1 and Cidea in rpWAT) or not affected by
FASN deﬁciency (Figure 5EeG). Thus, the results depicted in Figures 4
and 6 indicate that along with enhanced systemic glucose tolerance,
induced FASN depletion within adipocytes in mature mice potently
induces browning of WAT primarily in subcutaneous fat depots.
The adiponectin-Cre mouse line used in our study induces deletion of
FASN in both WAT and BAT, as illustrated in Figures 4B and 6A. We
therefore examined whether white and brown adipocyte FASN deﬁ-
ciency affects the BAT thermogenesis program, like the effects
observed in iWAT (Figure 5). Despite a strong suppression of FASN
protein in BAT from TAM treated iAdFASNKO mice (Figure 6A), the
expression of several thermogenesis-related genes in brown adipo-
cytes, including Ucp1, Cidea, Pgc1a, and Pdk4, was not affected by
FASN deletion (Figure 6C). Furthermore, no gross histological changes
were detected in BAT following depletion of FASN, as assessed by
(H&E) staining (Figure 6B). Thus, while induction of FASN deletion in
white and brown adipocytes caused a marked upregulation of
expression of thermogenesis-related genes and enhances browning in
iWAT (Figure 5), BAT from mice under these same conditions did not
appear to be affected by the absence of FASN enzyme in these
experiments.
3.4. UCP1-cre driven FASN knockout in brown adipocytes does not
improve glucose tolerance or browning of iWAT
To evaluate whether suppression of FASN in brown adipocytes could
account for the iWAT browning and improved insulin sensitivity
phenotype noted in the iAdFASNKO mice, FASNﬂox/ﬂox animals were
crossed to mice expressing a Cre-transgene driven by the UCP1-
promoter to speciﬁcally delete FASN only in brown adipocytes
(UCP1-FASNKO mice). FASNﬂox/ﬂox littermates that do not express Cre-
recombinase were used as controls. We conﬁrmed speciﬁc deletion of
FASN in BAT, but not in iWAT or eWAT adipose tissue depots in UCP1-
FASNKO mice (Figure 7A). Additionally, FASN protein levels were
preserved in liver, pancreas, and skeletal muscle from UCP1-FASNKO
mice (Supplementary Figure 4A). However, as illustrated in Figure 7A,
we found that deleting FASN only in BAT failed to elicit increases in
UCP1 expression and browning of iWAT. Furthermore, deletion of FASN
Figure 6: Inducible adiponectin-Cre driven FASN deletion in adipocytes of mature mice does not enhance UCP1 expression and the thermogenic program in BAT. (A):
Inducible deletion of adipocyte FASN does not affect UCP1 protein in BAT. Tissue lysates from controls and iAdFASNKO mice were immunoblotted for FASN, UCP1, or actin as
indicated. (B): H&E staining of BAT from control and iAdFASNKO mice reveals no major morphological changes in BAT upon FASN deletion. Depicted are representative images of
5e7 mice per group. (C): qRT-PCR was performed for quantiﬁcations of indicated genes in BAT from controls and iAdFASNKO mice. N ¼ 5e7 per group. *P < 0.05; ***P < 0.001.
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in brown adipocytes did not affect the BAT thermogenic program,
evidenced by lack of any detectable effects of FASN depletion on
expression of thermogenesis-related genes (Figure 7B).
To assess whether brown adipocyte FASN ablation improves whole-
body glucose metabolism in obese mice, control and UCP1-FASNKO
mice were challenged with an HFD for 12 weeks. Control littermates
and UCP1-FASNKO animals gained similar weight upon high-fat
feeding, and body weights were unchanged between groups
(Supplementary Figure 4B). Moreover, no alterations in GTT results were
observed among control versus UCP1-FASNKO animals on chow or HFD
(Figure 7D). Although BAT histology of UCP1-FASNKO mice revealed a
slight decrease in brown adipocyte lipid droplet size compared to
controls (Figure 7C), this modest alteration was not associated with
signiﬁcant changes in the BAT thermogenic program (Figure 7B). Thus,
these results indicate that brown adipocyte FASN ablation does not
enhance iWAT browning or improve insulin sensitivity in obese mice.
The iWAT browning and increased glucose tolerance (Figures 4 and 5)
in obese mice lacking FASN in both white and brown adipocytes thus
appears to be due to depletion of FASN in white adipocytes.
3.5. Adipose FASN KO enhances sympathetic nerve outﬂow in
iWAT
The inducible deletion of FASN in adipocytes depicted in Figures 4 and
5 indicates that reduced FASN expression in WAT can drive a program
Figure 7: UCP1-Cre driven FASN deletion in brown adipocytes of mature mice does not improve glucose tolerance or browning of iWAT. (A): Adipose tissue lysates from
control and UCP1-FASNKO mice were immunoblotted for FASN, UCP1, or tubulin protein as indicated. (B): qRT-PCR was performed for quantiﬁcations of indicated genes in BAT
from controls and UCP1-FASNKO mice. N ¼ 7e10. (C): H&E staining of BAT from control and UCP1-FASNKO mice. Depicted are representative images of 5e7 mice per group. (D):
Diet-induced glucose intolerance is not ameliorated in UCP1-FASNKO mice. Control and UCP1-FASNKO mice were fed with chow or HFD for 12 weeks and then GTT performed.
N ¼ 3e6 mice per group. ****P < 0.0001.
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of adaptive thermogenesis in vivo. Based on extensive data [18,50e
53] indicating that a major pathway of iWAT browning is through
activation of the sympathetic nervous system (SNS), we evaluated
whether adipocyte FASN KO elicits localized SNS activation to cause
upregulation of UCP1 and expression of other browning genes in iWAT.
To address this question, the effects of adipocyte FASN deletion on
neuronal tyrosine hydroxylase (TH) and neuropeptide-Y (NPY) levels in
iWAT were investigated. As shown in Figure 8A, a marked increase
in both TH and NPY contents were detected in iWAT from iAdFASNKO
mice. Moreover, these results were conﬁrmed by immunohisto-
chemistry and immunoﬂuorescence of whole iWAT from mice deﬁcient
in FASN, which showed marked increases in staining intensity and in
the number of locations of staining with anti-TH antibody (Figure 8C). In
addition, cAMP signaling in iWAT was induced upon FASN KO, based
on increases in phospho-perilipin, perilipin, and phospho-HSL levels
(Figure 8B) and measurements of adipocyte cAMP itself (data not
shown). Interestingly, the enhanced TH in iWAT depleted of FASN is
reﬂected at the protein level, but not at the mRNA level (Figure 8D).
Figure 8: Adipose FASN KO enhances sympathetic nerve outﬂow in iWAT. (AeB): FASN deletion in adipocytes of mature mice increases tyrosine hydroxylase (TH) and
neuropeptide Y (NPY) content and activates the PKA signaling pathway in iWAT. Depicted are representative immunoblots to detect FASN, TH, NPY, and tubulin (A), phospho-HSL,
phospho-perilipin, and perilipin (B) levels in iWAT from control or iAdFASNKO mice. (C): Immunohistochemistry (top panels) and immunoﬂuorescence (bottom panels) analysis for
detection of TH content in iWAT from control and iAdFASNKO mice. (D): Quantiﬁcation of Th mRNA and TH protein levels in iWAT upon induction of adipocyte FASN deletion. Th
mRNA was quantiﬁed by qPCR and TH protein levels through densitometry from immunoblot data shown in A. N ¼ 6e8 mice per group. *P < 0.05. (E): Proposed model shows
how deletion of FASN in white adipocytes may enhance adipose browning through neuronal circuit regulation.
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These data strongly indicate that the TH signals we detect are derived
from neurites projecting into adipose tissue rather than from other cell
types inﬁltrating the tissue. Altogether, these results are consistent
with the hypothesis that adipocyte DNL activity is linked to control of
local SNS activity.
The data in Figure 8 indicate that an intact animal may induce adi-
pose browning in response to adipocyte FASN depletion and predict
that cell autonomous effects of FASN deletion to enhance UCP1
expression may not operate under the conditions of our experiments.
To address this question, primary preadipocytes of WAT from
inducible-UBC-Cre-FASNKO mice were isolated and differentiated
into adipocytes. The mature adipocytes were then treated with TAM
or control conditions to induce FASN depletion, and the effect of FASN
ablation on Ucp1 mRNA expression in these cultured adipocytes
in vitro was evaluated. As shown in Figure 9A,B, endogenous Fasn
mRNA and protein levels were efﬁciently decreased by TAM treat-
ment of the cells derived from inducible-UBC-Cre-FASNKO mice but
not by vehicle control treatment. Moreover, loss of FASN from
differentiated adipocytes caused a marked reduction in [14C]-glucose
conversion into fatty acids, conﬁrming inhibition of the DNL pathway
in adipocytes upon deletion of FASN (Figure 9C). To determine
whether deletion of FASN increases thermogenesis-related gene
expression cell autonomously, primary adipocytes depleted or not of
FASN enzyme were treated for 4 or 24 h with indicated doses of the
b3-adrenoreceptor agonist CL316243, followed by Ucp1 mRNA
quantiﬁcation. As shown in Figure 9D,E, loss of FASN from differ-
entiated adipocytes did not enhance Ucp1 mRNA expression in either
basal or CL316243-stimulated conditions.
To further investigate whether suppression of DNL affects UCP1
expression in vitro, we treated differentiated adipocytes with the potent
FASN inhibitor platensimycin [46,47] then stimulated the cells with
CL316243 and examined Ucp1 expression. Despite the strong inhi-
bition of [14C]-glucose incorporation into fatty acids (Figure 9F), pla-
tensimycin treatment failed to enhance Ucp1 expression in basal or CL-
stimulated adipocytes (Figure 9G). Therefore, inhibition of DNL does
not enhance thermogenic gene expression in cultured primary
Figure 9: Inhibition of DNL does not enhance thermogenic gene expression in cultured primary iWAT adipocytes in vitro. (A): Subcutaneous preadipocytes in the SVF of
inguinal fat from inducible-UBC-Cre-FASNKO mice were differentiated in vitro into mature adipocytes. The mature adipocytes were treated with vehicle or TAM to induce FASN
deletion. Depicted in (A) is the qPCR quantiﬁcation of Fasn mRNA in control or TAM-treated cells. (B) Immunoblots to detect FASN and tubulin protein expression levels in control
and TAM-treated adipocytes. (C): Insulin-stimulated [14C]-Glucose conversion into fatty acids in control or in FASN-deleted primary adipocytes. (DeE) mRNA levels of Ucp1 in
control and FASN KO adipocytes stimulated for 4 or 24 h with indicated doses of CL316243 were determined. (F): Primary adipocytes from WT mice were pretreated with 0.1 mM
of FASN inhibitor platensimycin, then the insulin stimulation of [14C]-Glucose into fatty acids determined. (G): mRNA levels of Ucp1 in control and in platensimycin-pretreated
adipocytes, stimulated for 4 h with indicated doses of CL316243, were determined. ****P < 0.0001.
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adipocytes derived from WAT, suggesting that the enhanced browning
in iWAT depleted from FASN (Figure 5) is not cell autonomous under
our experimental conditions.
4. DISCUSSION
The major ﬁnding of these present studies indicates that disruption of
adipocyte FASN, the ﬁnal enzyme in the highly regulated DNL pathway
(Figures 1e3), initiates neuronal signaling that triggers sympathetic
stimulation of iWAT (Figure 8), activation of the cAMP pathway
(Figure 8) and browning of this adipose depot (Figures 4 and 5). These
effects are associated with marked upregulation of the expression of
iWAT UCP1 and other genes characteristic of BAT (Figure 5), expansion
of beige/brite cells with a multilocular phenotype in iWAT (Figure 5), and
improved glucose tolerance (Figure 4). Enhanced iWAT sympathetic
innervation upon adipocyte FASN depletion is supported by increased
abundance of TH and NPY in this adipose depot and induction of cAMP
signaling (Figure 8). That this is a major mechanism of iWAT browning
in iAdFASNKO mice is further supported by the failure of isolated pri-
mary adipocytes to display UCP1 expression or other characteristics of
beige/brite cells in vitro upon FASN depletion (Figure 9). Thus, intact
mice manifest iWAT browning with adipocyte FASN knockout through a
fully functional neuronal network. Taken together, these data demon-
strate that DNL, a key pathway of lipid metabolism in adipocytes, may
be coupled to modulation of adipose sympathetic tone, which in turn
controls major adipose tissue functions including expansion of beige/
brite cells. This pathway of adipocyte-neuron crosstalk may also have
major implications for control of whole body metabolic homeostasis.
An important question raised by our results is whether the enhanced
browning of iWAT in iAdFASNKO mice is secondary to effects initiated in
BAT orWAT or both, since adipocytes in both depots are depleted of FASN
in these mice. Compensatory mechanisms of WAT browning due to in-
hibition of BAT thermogenesis have been reported [18,54], for example,
upon genetic ablation of the BMP receptor (Bmpr1a) in brown adipocyte
progenitor cells [54]. This leads to a paucity of BAT, compensatory
increased sympathetic input to WAT, and browning [54]. We addressed
this possibility by examining thermogenesis in both BAT and WAT from
iAdFASNKO mice as described above as well as from UCP1-FASNKO
mice, which lack FASN only in brown adipocytes. Despite the efﬁcient
depletion of FASN protein in brown adipocytes from both mouse lines, no
changes in thermogenic gene expression in BATwere detected (Figures 6
and 7), indicating that the FASN pathway in BAT does not regulate BAT
thermogenesis under the experimental conditions used in our study.
Notably, suppression of FASN in brown adipocytes also did not promote
browning of WAT and failed to improve systemic insulin sensitivity in
obese mice (Figure 7) as is the case for iAdFASNKOmice. These ﬁndings
indicate that FASN deletion in WAT, not BAT, must bemediating the iWAT
browning observed in iAdFASNKOmice (Figure 5). The strong implication
of these ﬁndings is that adipocytes in WAT initiate neuronal signaling in a
WAT tissue-dependent manner rather than through a compensatory
mode in response to BAT dysfunction.
Previous studies have addressed the point that adipocyte DNL is a
highly regulated pathway, as in fasting [55] and obesity [19,20,56,57],
and it is generally correlated with the degree of systemic insulin
sensitivity [27,28,37,40,56,57]. Our studies further conﬁrm that sup-
pression of the adipose DNL pathway and deterioration of systemic
glucose metabolism are tightly correlated very early in obesity
(Figures 1e3), even when Akt is fully sensitive to insulin (Figure 2).
Several reports have suggested that adipocyte DNL activity is causative
in mediating improved systemic glucose tolerance based on genetic
manipulation of upstream components of the pathway to modulate
production of putative insulin sensitizing lipids [29,37,38]. On the other
hand, previous work on the constitutive deletion of adipocyte FASN led
to the opposite conclusion [31]. These confounding results prompted
us to use a more acute FASN deletion model that could be used in
mature mice (iAdFASNKO mice), eliminating possible effects of FASN
loss during early mouse development. Our results using this iAd-
FASNKO mouse model support the concept that FASN controls a
pathway that normally suppresses iWAT browning and glucose toler-
ance, and that inhibition of DNL releases this suppression through
activation of neuronal signaling and increased sympathetic activity.
However, depletion of FASN does not exactly mimic the decreased DNL
that occurs in obesity since other enzymes in the DNL pathway are also
downregulated in HFD mice. Therefore, it is not yet clear how the
results presented here relate to the body of literature suggesting that
adipocyte DNL is actually beneﬁcial to glucose homeostasis. Such
clariﬁcation will likely require experiments designed to elucidate the
molecular mechanisms through which adipocyte FASN depletion en-
hances adipose tissue TH levels.
There is a close anatomical and functional relationship between adipose
tissue and SNS and the interplay between these two organs is vital to
energy balance and metabolic homeostasis. On the one hand, BAT is
highly innervated, with extensive sympathetic and sensory nerves that
secrete factors to regulate lipolysis and thermogenesis [58], while WAT
is less innervated [53] but does require neuronal secretion of cate-
cholamines for stimulation of lipolysis during fasting [59]. Recent
research shows that stimulation of cAMP is propagated in WAT through
the action of the gap junction protein connexin 43, thus amplifying the
effects of localized b adrenergic stimulation and increasing the
browning of WAT [60]. Importantly, blocking SNS outﬂow in WAT
through local denervation suppresses both cold-induced thermogenesis
in BAT and browning in WAT, consistent with an essential role of SNS in
adipose tissue physiology [51e53,60,61]. On the other hand, adipose-
derived factors, such as leptin [62e65] and fatty acids from lipolysis,
activate local sensory neurons in WAT to elicit thermoregulation in BAT
[61]. Moreover, deletion of leptin signaling in sensory neurons results in
obesity [64]. Altogether, these studies highlight the existence of an
active inter-organ communication between adipose tissue and brain,
indispensable to maintain energy and metabolic balances. Our ﬁndings
add to the understanding of this crosstalk between adipose tissue and
the nervous system, and pinpoint the metabolic pathway of DNL as a
potential aspect of the mechanism whereby this crosstalk is mediated.
Might signaling by the adipocyte DNL pathway to modulate adipose
sympathetic tone be an important mechanism of regulation under
physiological conditions? While direct data are not available, fasting
and refeeding would seem to be good candidate physiological states
for such control to occur. For example, the virtual complete blockade of
adipocyte FASN activity during fasting, like the experimental FASN
depletion shown here (Figure 4), would be a logical contributor to the
enhancement of sympathetic activity in iWAT known to occur upon
food restriction. Interestingly, DNL contributes very little to total fat
deposition within the lipid droplets of adipocytes, which mostly derives
from lipoprotein lipase (LPL)-mediated hydrolysis of circulating lipo-
proteins [24e26,66]. This suggests that DNL has other roles in the
adipocyte. Its tight relationship with a variety of signaling molecules
and key substrates for other major pathways, for example acetyl CoA
as substrate for protein acetylations [33,34] and palmitate as substrate
for protein palmitoylations [35,36], may be indicative of high impact
regulatory roles, as exempliﬁed by neuronal modulation shown here. A
key question for future studies is what are the cell autonomous
mechanisms triggered by FASN depletion that mediate activation of
neuronal stimulation.
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While the role of adipose tissue in regulation of whole body metabolism
is now well established, less is known about the signaling mechanisms
and pathways within adipocytes that control systemic homeostasis.
Over the last two decades, however, the contribution of adipose-
derived molecules to whole body glucose metabolism has been
intensively investigated and a role for these molecules in systemic
metabolism through activation of central nervous system (CNS) has
been proposed [1,51,61e64]. For instance, adipose secretion of leptin
exerts some of its systemic effects on metabolism partially through
activation of sensory nerves in adipose tissue [64]. Also, free fatty
acids derived from adipocyte lipolysis seem to function as mediators of
adipocyte-neuron communications, as they appear to stimulate local
sensory nerves in WAT eliciting thermogenesis in BAT [61]. None-
theless, whether the adipose DNL pathway can produce signaling
metabolites that control SNS innervation in WAT had not been
demonstrated previously. Therefore, our study describes for the ﬁrst
time a potentially important link between the adipocyte DNL pathway
and the SNS outﬂow to WAT. This connection appears to be func-
tionally relevant, as inhibition of adipose DNL enhanced WAT inner-
vation along with improved energy and systemic metabolic
homeostasis in obese mice (Figures 4, 5, and 8). Altogether, these
results are consistent with the hypothesis that metabolites or other
factors derived from blockade of the adipocyte DNL pathway may
control the activation of local afferent neurons. According to this model,
upon deletion of adipocyte FASN and inhibition of DNL, these activated
sensory neurons signal to the CNS to enhance SNS expansion and
browning in iWAT (Figure 8E). However, our data do not rule out direct
effects of FASN depletion on sympathetic ﬁbers in adipose tissue. In
any case, we hypothesize that the adipose DNL pathway may function
as a ﬁne-tuned control mechanism for SNS activation in WAT and may
be essential for optimal energy balance and metabolic homeostasis.
Although inducible knockout mouse models are valuable tools to study
post-developmental function of genes, one caveat is that some non-
speciﬁc effects associated with TAM treatment, particularly on adi-
pose cell differentiation, could make the use of TAM-inducible mouse
lines less suitable for metabolic studies [67]. Nevertheless, the results
described in our studies are clearly due to FASN deletion, as control
Cre (/) mice treated with same doses of TAM did not display WAT
browning or changes in glucose tolerance (Figures 4 and 5). Also, as
expected, FASN protein levels in adipocytes from Cre (/) mice were
not affected by the drug treatment (Figures 4e9).
5. CONCLUSIONS
In summary, the ﬁndings presented here suggest that suppression of
FASN in white adipocytes from mature mice enhance sympathetic
activity and induce browning in WAT and improve glucose homeostasis
in obese mice. These data support the hypothesis that fatty acid
biosynthesis in white adipocytes controls thermogenic programming in
iWAT and systemic metabolic homeostasis through neuronal regula-
tion. This hypothetical pathway may also be relevant to dysfunctions in
systemic glucose tolerance that occur in obesity and diabetes [68]. A
key question raised by these results relates to the molecular identity of
the signal or signals arising from the adipocyte DNL pathway that
activate neuronal signaling. Identiﬁcation of such signals will be the
focus of future experiments.
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